Michael is a partner in Simon-Kucher's Life Sciences division and is based in the New York office.
Since joining Simon-Kucher in 2013, he has supported over 20 pharmaceutical companies with more than 25 assets on pricing and market access strategy. This experience includes indications in oncology, orphan diseases, vaccines, and primary care in over 25 countries spanning North and South America, Europe, and Asia. His consulting projects have focused on product launch, loss of exclusivity (LOE) planning, and competitor defense strategies.
Michael graduated from the University of Pennsylvania with a BSc in economics with a concentration in finance and a BA in neuroscience. His studies at Penn focused on the intersection between business and science in the life sciences industry. Michael also has bench research experience at Columbia University in the City of New York, University of Pennsylvania, and Merck & Co. (formerly Cubist Pharmaceuticals).